We are live on ! Find out more
ELOS

Syneron Medical
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

57 hedge funds and large institutions have $196M invested in Syneron Medical in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

11% more capital inflows, than outflows

Capital inflows: $40.3M | Capital outflows: $36.4M

14% less funds holding

Funds holding: 66 → 57 (-9)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

89% less call options, than puts

Call options by funds: $2K | Put options by funds: $19K

Holders
57
Holders Change
-9
Holders Change %
-13.64%
% of All Funds
1.49%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
8
Increased
18
Reduced
16
Closed
17
Calls
$2​K
Puts
$19​K
Net Calls
-⁠$17​K
Net Calls Change
-⁠$222​K

ELOS Hedge Fund Activity: Q4 2015 in Review

57 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical (ELOS) for Q4 2015, worth a combined $196M — up 8.8% from $180M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ELOS and 8 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 18 added.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $11.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $14.9M sold.

  • 57 institutional investors held Syneron Medical (ELOS) as of Q4 2015, down from 66 in Q3 2015.
  • Funds reported $196M of Syneron Medical stock for Q4 2015, up 8.8% quarter-over-quarter.
  • 8 funds opened new Syneron Medical positions in Q4 2015 and 17 closed out, a net change of -9 holders.
  • The largest Syneron Medical buyer in Q4 2015 was Camber Capital Management, an estimated $11.5M added.
  • The largest Syneron Medical seller in Q4 2015 was Deerfield Management, an estimated $14.9M sold.

Based on aggregated 13F filings for Q4 2015.